Sökning: id:"swepub:oai:gup.ub.gu.se/53062" >
Outcome of children...
Outcome of children with high-risk acute lymphoblastic leukemia (HR-ALL): Nordic results on an intensive regimen with restricted central nervous system irradiation
-
Saarinen-Pihkala, U. M. (författare)
-
Gustafsson, G. (författare)
-
Carlsen, N. (författare)
-
visa fler...
-
Flaegstad, T. (författare)
-
Forestier, E. (författare)
-
Glomstein, A. (författare)
-
Kristinsson, J. (författare)
-
Lanning, M. (författare)
-
Schroeder, H. (författare)
-
- Mellander, Lotta, 1941 (författare)
- Gothenburg University,Göteborgs universitet,Institutionen för kvinnors och barns hälsa, Avdelningen för pediatrik,Institute for the Health of Women and Children, Dept of Paediatrics
-
visa färre...
-
(creator_code:org_t)
- 2004
- 2004
- Engelska.
-
Ingår i: Pediatr Blood Cancer. - 1545-5009. ; 42:1, s. 8-23
- Relaterad länk:
-
https://gup.ub.gu.se...
Abstract
Ämnesord
Stäng
- BACKGROUND: Improvement in outcome of childhood high-risk (HR) ALL was sought with a very intensive Nordic protocol leaving most patients without CNS-RT. METHODS: A total of 426 consecutive children entered the NOPHO-92 HR-ALL program. HR criteria included WBC > or =50 x 10(9)/L, CNS or testicular involvement, T-cell, lymphomatous features, t(9;22), t(4;11), or slow response. Of these, 152 children had very high risk (VHR) with special definitions. CNS consolidation was based on high-dose MTX (8 g/m2) and ARA-C (12 g/m2) alternating. VHR patients also received cranial RT. RESULTS: The 9-year EFS was 61 +/- 3%, OS 74 +/- 2%, and EFS for T-ALL 62 +/- 4%. Cumulative incidence of isolated CNS relapse was 4.7 +/- 1%, and CNS relapse in total 9.9 +/- 2%. Poor prognostic factors were WBC > or =200 x 10(9)/L and a very slow response. CONCLUSIONS: HR-ALL was successfully treated on the NOPHO-92 regimen, with a relatively low CNS relapse rate for non-irradiated children. WBC > or =200 x 10(9)/L and very slow response emerged as strong poor prognostic factors.
Nyckelord
- Adolescent
- dosage/*therapeutic use
- Central Nervous System Neoplasms/*therapy
- Child
- Child
- Preschool
- Cohort Studies
- Combined Modality Therapy
- *Cranial Irradiation
- Cytarabine/administration & dosage
- Disease-Free Survival
- Female
- Humans
- Infant
- Leukemia
- Lymphocytic
- Acute/*therapy
- Male
- Methotrexate/administration & dosage
- Risk Factors
- Stem Cell Transplantation
- Transplantation
- Homologous
- Treatment Outcome
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
Till lärosätets databas